Engerix-b 20 MCG/ML syrnml
Ended Awarded Last action
- Contract number
- SPE2DR26F1W98
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,111
Award facts
- Contract value 100% obligated
- $10,110.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 23, 2026, provides ENGERIX-B 20 micrograms per milliliter vaccine syringes to the Defense Logistics Agency (DLA) through AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The firm fixed-price delivery order has a ceiling value of $10,110.90 with an ultimate completion date of January 26, 2026, and was awarded on a competitive, non-set-aside basis. This order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the prime indefinite delivery contract with DLA. The DLA Medical Supply Chain utilizes this contract vehicle to procure critical medical commodities, including specialty medications, vaccines, and related medical supplies across multiple therapeutic domains to support military treatment facilities and the Defense Health Agency. The vaccine delivery under this order aligns with the DLA's broader mission to maintain readiness and support the healthcare requirements of military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F1W98?
SPE2DR26F1W98 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F1W98 worth?
The government has obligated $10,111 on SPE2DR26F1W98.
Is contract SPE2DR26F1W98 an order under another contract?
Yes. SPE2DR26F1W98 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W98 competed?
The extent of competition for SPE2DR26F1W98 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award